⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL433762 | 0.97 | — | — | |
| SCHEMBL1983075 | 0.97 | — | — | |
| SCHEMBL433761 | 0.97 | — | — | |
| SCHEMBL5049710 | 0.81 | — | — | |
| SCHEMBL574582 | 0.78 | — | — | |
| SCHEMBL574583 | 0.78 | — | — | |
| SCHEMBL17633731 | 0.75 | ALDH1A1 (0.30) | — | |
| SCHEMBL17633732 | 0.75 | ALDH1A1 (0.30) | — | |
| SCHEMBL25415103 | 0.75 | — | — | |
| SCHEMBL28411757 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1798600-B1 | Use of a porhine agent for reducing the potential of ghosting in an imaging member | XEROX CORP (US) | 2012-10-10 | — | — | EP | disclosed |
| US-7527904-B2 | Imaging member | XEROX CORPORATION (US) | 2009-05-05 | — | — | US | disclosed |
| US-20070141490-A1 | Imaging member | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2007-06-21 | — | — | US | disclosed |
| EP-1798600-A1 | Imaging Member | Xerox Corporation (US) | 2007-06-20 | — | — | EP | disclosed |